← Leaderboards
Martin Lipkin
Strang Cancer Prevention Center
$1,557,440
Attributed
$1,557,440
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,557,440 · 4
By mechanism
N01$1,557,440 · 4
Top collaborators
No co-investigators on record.
Most similar at Strang Cancer Prevention Center
Same institution · by research overlap
- Monica M Bertagnolli$89,510,834
Others in their field
Top investigators on “Biomarker”
- David R. Weir · University Of Michigan At Ann Arbor$368,126,077
- Leonard Freedman · Leidos Biomedical Research, Inc.$248,231,562
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$217,859,034
- Ralph Parchment · Leidos Biomedical Research, Inc.$186,322,680
- Randall J Bateman · Washington University$182,177,358
- Paul S. Aisen · Cognition Therapeutics, Inc.$182,141,353
Research focus
BiomarkerDrug Screening /EvaluationCancer PreventionChemopreventionColorectal NeoplasmsGenetically Modified AnimalsLaboratory MouseDisease /Disorder ModelChickensDna DamageDna MethylationFatty Acid MetabolismFibroblastsFolateHistopathologyHuman TissueLinoleateMelanomaNeoplasm /Cancer EpidemiologyNeoplasm /Cancer GeneticsNeoplastic GrowthNeoplastic ProcessNutrition Aspect Of CancerNutrition Related Tag
Grant awards (4)
EVALUATION OF INTERMEDIATE ENDPOINTS AND THEIR MODULATIO$610,578
N01 · FY2000 · CN
MECHANISM-BASED IN VITRO SCREENING OF CHEMOPREVENTIVE AG$497,962
N01 · FY2000 · CN
EFFECTS OF FOLATE-DEFICIENT WESTERN-STYLE ON TRANSGENIC$293,632
N01 · FY2000 · CN
INTERMEDIATE BIOMARKERS FOR COLORECTAL CANCER &MELANOMA$155,268
N01 · FY2000 · CN